Melanogenesis, the intricate process of
melanin synthesis, is central to skin pigmentation and photoprotection and is regulated by various signaling pathways and
transcription factors. To develop potential
skin-whitening agents, we used B16F1
melanoma cells to investigate the inhibitory effects of anhydrous
alum on melanogenesis and its underlying molecular mechanisms. Anhydrous
alum (KAl(SO4)2) with high purity (>99%), which is generated through the heat-treatment of hydrated
alum (KAl(SO4)2·12H2O) at 400 °C, potentiates a significant reduction in
melanin content without cytotoxicity. Anhydrous
alum downregulates the master regulator of melanogenesis,
microphthalmia-associated transcription factor (MITF), which targets key genes involved in melanogenesis, thereby inhibiting α-
melanocyte-stimulating hormone (α-
MSH)-induced melanogenesis. Phosphorylation of the
cAMP response element-binding protein, which acts as a co-activator of MITF gene expression, is attenuated by anhydrous
alum, resulting in compromised MITF transcription. Notably, anhydrous
alum promoted
extracellular signal-regulated kinase phosphorylation, leading to the impaired nuclear localization of MITF. Overall, these results demonstrated the generation and mode of action of anhydrous
alum in B16F1 cells, which constitutes a promising option for cosmetic or
therapeutic use.